Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy by Katsicas M, Russo R

Connect to this object online.

Patients with early-onset systemic juvenile idiopathic arthritis show more inflammation and worse outcome by Katsicas M, Russo R

Connect to this object online.

The prospective juvenile systemic sclerosis inceptions cohort - <url>http://www.juvenile-scleroderma.com</url> by Foeldvari I, Anton J, Chaitow J, Baildam E, Higgins G, Lehman T, Len C, Maillard S, Reiff A, Russo R, Zulian F

Connect to this object online.

13.4 High frequency of CNS involvement in linear scleroderma of the face by Parolin M, Russo R, Corona F, de Oliveira SKF, Nowakowska EM, Sztajnbok F, Chaitow J, Espada G, Desjonqueres M, Ullman S, Zulian F

Connect to this object online.

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America by Trail L, Ferrari C, Cuttica R, Katsicas MM, Russo R, Bandeira M, Ferriani V, Oliveira S, Saad-Magalhaes C, Silva CA, Baca V, Burgos-Vargas R, Solis-Vallejo E, Maillard S, Pilkington C, Barcellona R, Beltramelli M, Breda L, Bruno C, Cimaz R, Cortis E, Gallizzi R, Garofalo F, Meini A, Podda R, Stabile A, Martini A, Ravelli A

Connect to this object online.

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients by Ferrari C, Trail L, Pilkington C, Maillard S, Cuttica R, Katsicas MM, Russo R, Bandeira M, Ferriani V, Oliveira S, Saad-Magalhaes C, Silva CA, Baca V, Burgos-Vargas R, Solis-Vallejo E, Alessio M, Alpigiani MG, Corona F, Falcini F, Gerloni V, Lepore L, Magni-Manzoni S, Zulian F, Ruperto N, Pistorio A, Felici E, Rossi F, Sala E, Martini A, Ravelli A

Connect to this object online.